Download Schizophrenia Research Study Opportunities

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Shifra Baruchson Arbib wikipedia , lookup

Personal information management wikipedia , lookup

Reconstructive memory wikipedia , lookup

Play (activity) wikipedia , lookup

Cyberpsychology wikipedia , lookup

Human multitasking wikipedia , lookup

Transcript
Seeking Study Participants
For more studies, turn to the other pages
U of M SCHIZOPHRENIA PROGRAM: 612-627-4840
“Switch or Stay” Studies: These studies are sponsored by the NIMH Schizophrenia
Trial Network (STN) to determine the benefit of changing medication. Adults diagnosed
with schizophrenia or schizoaffective disorder will continue treatment with their regular
providers and come to the U of MN research office seven times in a year-long study.
Contact the Program at 612-627-4840 or [email protected] for more information
or if interested in participating.
Metabolic Study: Patients who are overweight with high cholesterol but not diabetes,
currently taking Zyprexa, Risperdal, or Seroquel are needed for a STN sponsored trial
called Comparison of Antipsychotics for Metabolic Problems (CAMP). The study will
compare the effect of an individualized nutrition/exercise program with a switch of
medication to Abilify over a 6 month period. Subjects must be 18-65 with a diagnosis of
schizophrenia or schizoaffective disorder. Antipsychotic medication, psychiatric care,
metabolic testing, and the behavioral program all at not cost to participants. Contact the
Program at 612-627-4840 or [email protected] for more information or if
interested in participating.
Long-Term Maintenance Study: Patient with schizophrenia currently taking
medication who are mildly ill and age 18 or over, will be treated with an investigation
drug for over 6 months, then if continue to be clinically stable, enter a placebo-controlled
phase for another 6 months. Subjects must have a caregiver who cans participate with
them in the study. Please contact the U of MN Schizophrenia Program at 612-627-4840
or [email protected] for more information.
Schizophrenia Brain Imaging Study at U of M: Volunteers are needed for a brain
imaging study at the University of Minnesota, Medical School, Department of Psychiatry.
If you have Schizophrenia or other related illnesses, and are between the ages of 18 and
60, you may be eligible for a MRI study. This is not a medication trial. A stipend is
offered. Flexible appointments are available to fit your scheduling needs. For more
information, please call Schizophrenia Research at (612) 627-4825 or email
[email protected]
Cognition Study: Patients with schizophrenia are needed for a 6 month study of an
investigational drug to improve cognition (attention, memory, problem-solving). Patients
continue their medication (Risperdal, Seroquel, Zyprexa or Abilify), adding the drug or
placebo. Flexible appointments are available. Study drug and lab tests at no cost to
participants. Please contact the Schizophrenia Research Team and 612-627-4840 or
[email protected]
Psychosis Study: Participants ages 65 and older are needed for a six-week study to
evaluate an investigational drug that is being studied to treat some psychiatric illnesses.
If you or someone you know are over 65 years of age and are diagnosed with psychosis
with symptoms such as delusions, hallucinations, excitement, hostility, or poor impulse
control. Participants must have a caregiver or nurse to assist with study visits and must
be willing to stay in the hospital or long term care facility for the first 8 days of the study.
Hospital and clinic costs, study drug, and lab tests at no cost to participants. Please
contact the Schizophrenia Research Team at 612-627-4840 or [email protected]
Seeking Study Participants
For more studies, turn to the other pages
Borderline Personality Disorder Study
Medication/Brain imaging study for females ages 18-45:
This study is an open-label (no placebo) olanzapine PET scan study: This study involves
12 visits, 3 which are brain imaging scans. Participants will have a Baseline MRI scan
and PET scan of their brains, then take olanzapine 2.5-7.5mg for the 1st 4 weeks, then
maintain a dose of 7.5mg for the remaining 4 weeks. Participants will then have a repeat
PET scan at the end of the 8 weeks. Participants need to be currently NOT taking any
psychiatric medication or have active substance abuse. Weekly assessment visits.
$25/visit. For more information, please call Ann at 612-273-9722.
Anorexia Nervosa Diary Study: Female volunteers age 18 and older with symptoms of
Anorexia Nervosa are needed for a study at the University of Minnesota. This is not a
treatment study. Compensation up to $200. For more information please call: 612-6271991.
Binge-Eating Research: Women (18-45) who are over weight and binge eat are invited
to participate in a paid research study at the University of Minnesota. Involves
evaluation, dietary histories, and metabolic testing, but not treatment. For information,
call 612-627-7926.
Obesity Research: Women (18-45) who are over weight are invited to participate in a
paid research study at the University of Minnesota. Involves evaluation, dietary histories,
and metabolic testing, but not treatment. For information, call 612-627-7926.
Eating Disorder Research Study: Women ages 18 and older who struggle with binge
eating and purging are needed for a research study providing free therapy. For more
information about this University of Minnesota Study, please call 612-627-1991.
Eating Disorder Study: Women ages 18 and older with symptoms of anorexia are
needed for a research study providing free psychotherapy. For more information about
this University of Minnesota study, please call Dr. Margit Berman at 612-625-9501.
Gambling Therapy Study:
Seeking volunteers for a treatment study for gambling addiction. Must be 18 years of age
or older to participate. Please call 612-273-9736 for more information.
Kleptomania (Compulsive Shoplifting) study:
Do you shoplift? Is it causing problems? Does it feel out of control? We are currently
seeking volunteers for a drug study for shoplifting. You must be 17 years of age or older
to participate. Please call 612-273-9736 for more information.
Trichotillomania (Hair-pulling) study:
Do you pull your hair? Does it feel out of control? We are currently seeking volunteers
for drug study for hair-pulling. Must be 18 years of age or older to participate. Please
call 612-273-9736 for more information.
Skin picking study:
Do you pick your skin? Is it causing problems? Does it feel out of control? Seeking
volunteers for a drug study for skin picking. Must be 18 years of age or older to
participate. Please call 612-273-9736 or 612-627-4363 for more information.
Sex addiction study:
Seeking volunteers for a research study using a medication for compulsive sexual
behaviour. Must be at least 21 years old. Please call 612-273-9736 or 612-627-4363 for
more information.
Methamphetamine Dependence Study:
Does crystal meth control your life? Are you trying to stop? Seeking volunteers for an
investigational drug treatment study for methamphetamine dependence. Must be 18
years of age or older to participate. Please call 612-273-9736 for more information.
Functional Brain Imaging Study: Researchers are looking to enroll volunteers ages 1019 with a schizophrenia spectrum disorder or individuals with no history of mental
illness. Individuals will be asked to complete two sessions. During the first session we
will conduct a thorough diagnostic interview. The second session involves mock
scanning and a functional MR scan. Families will receive a written report on the findings
of the clinical interview and will be paid for participating. Call Dr. Tonya White or
Angie at 612-273-9834 to learn more.
If you have access to the world wide web (www), find http://www.ahc.umn.edu/ and choose Research and Clinical Trials for a
more-complete list of trials within the Department of Psychiatry.
University of Minnesota, Department of Psychiatry, Ambulatory Research Center